OZURDEX .7 mg/1 (Dexamethasone IMPLANT) .7 mg/1

OZURDEX .7 mg/1 is a dexamethasone implant designed for intravitreal use. This medication is used to treat inflammation and swelling in the eye, offering targeted relief. Learn more about its uses and effects.

Strength

.7 mg/1

Pack Size

1 POUCH in 1 CARTON (0023-3348-08) / 1 IMPLANT in 1 POUCH

Manufacturer / TM Owner

Allergan, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OZURDEX .7 mg/1 is primarily used for the treatment of inflammation and swelling in the eye. This dexamethasone implant is often utilized in conditions where localized treatment is necessary. Patients may wonder, 'What is OZURDEX used for?' It is commonly prescribed for managing symptoms related to ocular inflammation.

Side Effects

OZURDEX .7 mg/1 works by reducing inflammation and swelling in the eye. Patients may experience relief from symptoms such as redness, pain, and discomfort. The effects of the implant are designed to be localized, targeting the specific area of inflammation.

Precautions & Warnings

Handling OZURDEX .7 mg/1 should be done with care, following the instructions provided by a healthcare professional. It is important to store the implant properly and use it as directed. Patients should be aware of any potential side effects and discuss them with their healthcare provider.

Avoid Interactions

OZURDEX .7 mg/1 may interact with other medications, particularly those that affect the immune system or inflammation. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also interact with the implant.

Frequently Asked Questions

OZURDEX is used to treat inflammation and swelling in the eye, often related to conditions like macular edema.

OZURDEX is administered as an intravitreal implant by a healthcare professional.

Common side effects may include eye discomfort, increased eye pressure, and vision changes.

Patients should consult their healthcare provider before using OZURDEX with other medications.

The onset of action can vary, but patients may experience relief from symptoms within a few days.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.